A critical discovery in cancer research is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This crucial cancer inhibitor protein is frequently inactivated in various kinds of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research